Integra LifeSciences Stock Target Price and Analyst Consensus
| IART Stock | USD 29.24 0.90 3.18% |
The current analyst and expert consensus on Integra LifeSciences is Buy with 5 hold recommendations. The current projected Integra LifeSciences target price consensus is 46.89 with 13 analyst opinions. One of the most common ways Integra LifeSciences analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Integra LifeSciences vendors, executives, and/or customers. Integra LifeSciences recommendation module provides expert sentiment on the projected Integra LifeSciences target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on Integra LifeSciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 42.67 | Highest Forecast 52.05 | Target Price 46.89 |
Integra |
It's important to approach Integra LifeSciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Integra LifeSciences price targets
Integra LifeSciences' stock target price is an estimate of its future price, usually made by analysts. Using Integra LifeSciences' target price to determine if it is a suitable investment can be done through the following steps:- Look at Integra LifeSciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Integra LifeSciences' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Integra LifeSciences Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Integra LifeSciences is a key component of Integra LifeSciences valuation and have some predictive power on the future returns of a Integra LifeSciences.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Integra LifeSciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Driverless Cars Invested over 200 shares | |
 | Adviser Favorites Invested few shares | |
 | Artificial Intelligence Invested few shares | |
Check out Macroaxis Advice on Integra LifeSciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Integra Stock analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
The data published in Integra LifeSciences' official financial statements usually reflect Integra LifeSciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Integra LifeSciences. For example, before you start analyzing numbers published by Integra accountants, it's critical to develop an understanding of what Integra LifeSciences' liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Integra LifeSciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Integra LifeSciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Integra LifeSciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Integra LifeSciences Holdings. Please utilize our Beneish M Score to check the likelihood of Integra LifeSciences' management manipulating its earnings.